Summary
No overall score for this company yet.
What speaks for it
- Revenue grew by 18% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
What to watch
None of the indicators we track raises a caution right now.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Is it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
Revenue grew by 18% a year over 5 years. Over the last 3 years it grew by 18% a year.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Small, at risk- Yield
- 2.77%
- Raised in a row
- 3 years
You receive $1.36 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.